Form 8-K - Current report:
SEC Accession No. 0001829126-24-008150
Filing Date
2024-12-06
Accepted
2024-12-06 17:03:26
Documents
15
Period of Report
2024-12-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opgeninc_8k.htm   iXBRL 8-K 36297
2 EXHIBIT 10.1 opgeninc_ex10-1.htm EX-10.1 34146
3 EXHIBIT 10.2 opgeninc_ex10-2.htm EX-10.2 29392
  Complete submission text file 0001829126-24-008150.txt   290765

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE opgn-20241204.xsd EX-101.SCH 2991
5 XBRL LABEL FILE opgn-20241204_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE opgn-20241204_pre.xml EX-101.PRE 22343
17 EXTRACTED XBRL INSTANCE DOCUMENT opgeninc_8k_htm.xml XML 3651
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 241533070
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)